outstand execut pretti much front buyer weak
buyer share weak yet anoth strong beat/rais quarter
continu impress pipelin progress soliri continu strength
rapidli expand margin profil see littl quibbl commerci coupl
quickli emerg well-balanc pipelin strong mix late
intermedi earli stage asset remain impress turnaround
effect manag team given perplex today weak
possibl attribut fear roch updat remain one
favorit larg cap well
non-gaap ep beat consensu pjc soliri
strength primarili driven gmg growth revenu beat consensu
pjc even drag order time guidanc rais
time year revenu guidanc previous
non-gaap ep guidanc previous
margin stori get better better even recent pipelin addit bring
increment spend oper margin guidanc still increas
manag care note mani offset
pipelin expans increas sg launch spend think robust revenu
growth coupl number larger trial roll make quit posit
margin outlook could prove estim conserv inde
would shock see oper margin rang
catalyst aplenti track file soliri nmo neuromyel optica earli
next year momentum ultomiri continu schedul feb
pdufa date pnh ahu top-line data anticip file
ultomiri ahu expect follow approv pnh
yet stock heard numer investor fear roch
updat chugai antibodi reason today weak
perplex roch commentari moder asset
especi sinc data inde would remind investor competit
updat cut way drug alreadi seen share safeti issu
rais estim remain buyer strong soliri growth expand margin
profil sever near-term catalyst tap like set rais
soliri total revenu estim chang price target
commerci regulatori clinic ip risk associ market pipelin product
alexion develop market therapi address rare diseas
discount back
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
base strong result updat guidanc rais soliri
revenu estim larg increas mg revenu bring
soliri revenu estim ahead top end guid rang
given manag tendenc toward conserv guidanc note total revenu
soliri guidanc increas everi earn call first three quarter
strong mg demand trend comfort estim total revenu
estim also increas roughli bring estim
also tweak expens tax estim bring estim within
guidanc new oper margin estim high end guid
rang also note slightli moder tax assumpt
ep estim bring ep estim
high end guid rang top-lin guidanc ep guidanc
increas earn call also note ep end
ahead high end manag guid rang issu earn call
surpris latest guidanc updat also prove conserv
chang price target share deriv appli multipl
ep discount back
page
collabor agreement
good sold
product sale
total revenu
sell gener administr
total revenu
statement oper
dollar except per share data
provis incom tax tax benefit
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
